The World Vaccine Congress Europe brings experts from the whole value chain under one roof. Speakers and delegates will share their insights on research, development and strategic partnering in the global vaccine industry. 450 delegates will discuss commercial and scientific issues in manufacturing, trials, strategy, regulation, emerging diseases, respiratory and therapeutics.
By attending World Vaccine Europe, delegates will gain a better understanding about:
– Finding ways to improve the development of Influenza, RSV, MERS and TB vaccines;
– Identifying business opportunities in relation to global threats like Zika, Malaria, Dengue and Ebola;
– Improving clinical trial performance from developing novel assays to creating clinical efficacy.
We will present our views on how R&D outsourcing can stimulate the innovation processes for vaccine developers. Practical case examples will be discussed and new horizons will be explored by sharing our latest assay innovation: The VirospotTM MN Assay.
Additional information can be found here, on the dedicated event website.